Oragenics, Inc. (OGEN) Operating income 2016–2025
Oragenics, Inc. (OGEN) annual operating income history from SEC filings — each fiscal year as reported.
-$9.4MFY2025 · since FY2016: -$8.5M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.4M | +11.3% |
| FY2024 | -$10.6M | +49.5% |
| FY2023 | -$20.9M | -45.0% |
| FY2022 | -$14.4M | +8.6% |
| FY2021 | -$15.8M | +40.8% |
| FY2020 | -$26.6M | -67.8% |
| FY2019 | -$15.9M | -58.9% |
| FY2018 | -$10.0M | -48.8% |
| FY2017 | -$6.7M | +21.4% |
| FY2016 | -$8.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice